SEC Form 4 · accession 0001140361-15-012357
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Mueller
Officer — VP, Corporate Controller
Period of report
Mar 16, 2015
Accepted (ET)
Mar 17, 2015 · 7:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 16, 2015 | A | 4,000 | $0.00 | A | 12,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF2 | $124.37 | Mar 16, 2015 | A | 9,000 | A | Sep 16, 2015 | Mar 15, 2025 | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1Restricted stock units granted on march 16, 2015. Price not applicable.
- F2Original option grant vests 6/48ths on September 16, 2015, and 1/48th on the 1st day of each month thereafter.